Business Context and Reporting Period
This Form 8-K Current Report was filed by Farmland Partners Inc. on May 6, 2022. The filing discloses the commencement of a new at-the-market equity offering program (the "Program") to raise capital for future farmland acquisitions and general corporate purposes.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on the authorization of a new equity distribution facility.
- Program Capacity: Up to $100,000,000 in aggregate offering price.
- Remaining Capacity from Prior Program: Approximately $10,000,000 remained available under the prior program commenced on October 29, 2021.
- Commission Rate: Sales agents are entitled to a commission not exceeding 2.0% of gross offering proceeds.
Material Changes
The material change reported is the execution of five new Equity Distribution Agreements with the following sales agents:
- Robert W. Baird & Co. Incorporated
- B. Riley Securities, Inc.
- Janney Montgomery Scott LLC
- Jefferies LLC
- Raymond James & Associates, Inc.
These agreements replace or supplement the prior at-the-market offering program, allowing the Company to issue and sell shares of its common stock through these agents.
Guidance, Outlook, and Risks
Use of Proceeds: The Company intends to use net proceeds to fund future acquisitions of farmland and for general corporate purposes, which may include originating secured loans to farmers.
Management Commentary and Risks:
- The Company has no obligation to sell any shares under the Program.
- Sales depend on market conditions, trading price of common stock, and capital needs.
- The Company or any Sales Agent may suspend the offering or terminate the agreements at any time.
- Sales may be made directly on the New York Stock Exchange, to market makers, or through electronic communications networks.
Investor Verification Checklist
- Verify the current trading price of Farmland Partners Inc. (FPI) common stock to assess potential dilution impact.
- Confirm the exact amount of shares sold under the prior program to validate the remaining $10 million capacity.
- Review the effective shelf registration statement (Form S-3, File No. 333-254834) for detailed terms.
- Monitor future filings for actual sales volumes and proceeds generated under the new Program.
- Check for any subsequent suspensions or terminations of the Distribution Agreements.